Dana-Farber’s Belfer Institute for Applied Cancer Science and Evotec Collaborate Wednesday, May 01, 2013 Research collaboration aimed at discovering and commercialising novel cancer treatments based on epigenetic drug mechanisms. Arrowhead Prices $36 Million Private Offering Wednesday, May 01, 2013 Arrowhead Research Corporation announced that it has priced a private offering with gross proceeds expected to be $36 million. The offering was priced at $1.83 per common share. Teva Expands Management Team Wednesday, May 01, 2013 Teva Pharmaceutical Industries Ltd. announced that Paul J. Sekhri has been appointed Group Executive Vice President, Global Business Development and Chief Strategy Officer. FORMA Therapeutics and Celgene Corporation Establish Broad Strategic Collaboration Wednesday, May 01, 2013 FORMA and Celgene will discover, develop and commercialize drug candidates to regulate protein homeostasis targets. Celator® Pharmaceuticals Raises $32.5 Million Completing a $39.3 Million Private Placement Financing Wednesday, May 01, 2013 Proceeds will support phase 3 study of CPX-351 in acute myeloid leukemia. Biologics Introduces Clinical Policy and Therapeutic Intelligence Office Wednesday, May 01, 2013 Biologics is pleased to announce the launch of its Clinical Policy and Therapeutic Intelligence Office. Sensile Medical Enters into an Agreement with scPharmaceuticals Wednesday, May 01, 2013 The SenseCore technology offers opportunities for improved therapy outcomes and healthcare cost reduction. OBT and Boehringer Ingelheim Enter Collaboration Monday, April 29, 2013 Collaboration to discover novel antibody targets in cancer. Genticel Secures EUR 18.2 Million (USD 23.7 million) in Capital Funding Friday, April 26, 2013 Dr. Rainer Strohmenger joins the supervisory board of Genticel.
|
|
|
| << | 3 4 5 6 7 8 9 | >> | | Showing Results 51 - 60 of 2380 |
|
|